JANSSEN-CILAG FARMACEUTICA, LDA secures contract for 2026 0126 - Invitation To Present A Proposal For The Acquisition Of Amivantamab 50 Mg Ml 7 Ml Sun Inj Frs Bosentan 32 Mg Comp Disp Bedaquiline 100 Mg Cap Comp Darunavir

Portugal, March 9 -- Portugal based JANSSEN-CILAG FARMACEUTICA, LDA has secured contract from Ipo Porto Fg, Epe for 2026 0126 - Invitation To Present A Proposal For The Acquisition Of Amivantamab 50 Mg Ml 7 Ml Sun Inj Frs Bosentan 32 Mg Comp Disp Bedaquiline 100 Mg Cap Comp Darunavir. The value of the contract is worth 3071712 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....